Fairfax Finl Hld Sub (FRFHF) 431.9900 $FRFHF Fairfax

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fairfax Finl Hld Sub (FRFHF) 431.9900 $FRFHF

Fairfax Announces Acquisition of Shares of Torstar
Marketwire - Thu Mar 20, 4:03PM CDT
Fairfax Financial Holdings Limited (TSX: FFH)(TSX: FFH.U) announced today that it has acquired, through certain of its subsidiaries, 2,385,350 Class B non-voting shares ("Class B Shares"), representing 3.4% of the outstanding Class B Shares of Torstar Corporation ("Torstar"), bringing its total holdings in Torstar to 15,899,650 Class B Shares or approximately 22.7% of the total Class B Shares outstanding. The shares were purchased through the facilities of the Toronto Stock Exchange at a price of $5.35 per Class B Share for investment purposes. The purchase was made in reliance on the normal course purchase exemption in section 100 of the Securities Act (Ontario). Fairfax continually reviews its investment alternatives and may purchase additional shares of Torstar from time to time in accordance with applicable laws.

Fairfax Announces Quarterly Dividend on Series C, Series E, Series G, Series I and Series K Preferred Shares
Marketwire - Mon Mar 03, 4:03PM CST
Fairfax Financial Holdings Limited (TSX: FFH)(TSX: FFH.U) announces that it has declared a quarterly dividend of C$0.359375 per share on its Series C Preferred Shares, C$0.296875 per share on its Series E Preferred Shares, C$0.3125 per share on its Series G Preferred Shares, C$0.3125 per share on its Series I Preferred Shares and C$0.3125 per share on its Series K Preferred Shares. The dividends are payable on March 31, 2014 to shareholders of record on March 17, 2014. Applicable Canadian withholding tax will be applied to dividends payable to non-residents of Canada.

Fairfax Financial Holdings Limited: Financial Results for the Year Ended December 31, 2013
Marketwire - Thu Feb 13, 4:37PM CST
(Note: All dollar amounts in this news release are expressed in U.S. dollars, except as otherwise noted. The financial results are reported under International Financial Reporting Standards, except as otherwise noted.)

The Keg Royalties Income Fund and Keg Restaurants Ltd. Announce Completion of the Sale of a 51% Interest in Keg Restaurants Ltd.
Marketwire - Tue Feb 04, 6:30PM CST
The Keg Royalties Income Fund (the "Fund") (TSX: KEG.UN) and Keg Restaurants Ltd. ("KRL") today announced that Fairfax Financial Holdings Limited ("Fairfax") has completed the transaction to acquire a 51% interest in KRL from David Aisenstat. Mr. Aisenstat will continue to hold the remaining 49% interest in KRL and he, along with the rest of the current KRL management team, will remain in operational control of The Keg.

Management Announcement for First Mercury Financial Corporation
PR Newswire - Tue Feb 04, 10:02AM CST
Crum & Forster ("C&F"), announced that Marc Adee has assumed the position of Chief Executive Officer of First Mercury Financial Corporation ("FMFC") and CoverX Corporation ("CoverX"), reporting to Doug Libby, Chairman and Chief Executive Officer. FMFC and CoverX are operating units of the Crum & Forster Enterprise and provide their services through First Mercury Insurance Company - a full service specialty liability insurer - and CoverXSpecialty - a producer with expertise in specialty lines, such as security, construction, and excess/umbrella. Crum & Forster Enterprise is part of Fairfax Financial Holdings.

Fairfax Announces Conference Call
Marketwire - Fri Jan 31, 1:31PM CST
Fairfax Financial Holdings Limited (TSX: FFH)(TSX: FFH.U) will hold a conference call at 8:30 a.m. Eastern Time on Friday, February 14, 2014 to discuss its 2013 year-end results which will be announced after the close of markets on Thursday, February 13 and will be available at that time on its website www.fairfax.ca. The call, consisting of a presentation by the company followed by a question period, may be accessed at (800) 857-9641 (Canada and U.S.) or 1 (517) 308-9408 (International) with the passcode "Fairfax".

Fairfax to Purchase Additional Convertible Debentures
Marketwire - Wed Jan 08, 12:31PM CST
BlackBerry(R) Limited (NASDAQ: BBRY)(TSX: BB), a world leader in mobile communications, announced today that Fairfax Financial Holdings Limited has agreed to purchase, through its subsidiaries, an additional $250,000,000 principal amount of 6% unsecured subordinated convertible debentures of BlackBerry (the "Debentures"). The additional Debentures will be purchased pursuant to the exercise of a previously-announced option that was granted in connection with BlackBerry's private placement of $1 billion principal amount of Debentures on November 13, 2013, and the transaction will be completed on or before January 16, 2014.

Fairfax Declares Annual Dividend
Marketwire - Fri Jan 03, 8:01AM CST
Fairfax Financial Holdings Limited (TSX: FFH)(TSX: FFH.U) announces that it has declared a dividend of US$10.00 per share on its outstanding multiple voting and subordinate voting shares, payable on January 28, 2014 to shareholders of record on January 21, 2014. Applicable Canadian withholding tax will be applied to dividends payable to non-residents of Canada.

BlackBerry in Value Territory?
at The Street - Mon Dec 23, 8:42AM CST
An Intriguing story, but challenges to rebound abound.

Fairfax Announces Acquisition of Shares of Reitmans
Marketwire - Fri Dec 20, 3:31PM CST
Fairfax Financial Holdings Limited ("Fairfax") (TSX: FFH)(TSX: FFH.U) announced today that it has acquired, through its subsidiaries, 2,000,000 Class A non-voting shares ("Class A Shares"), representing 3.9% of the outstanding Class A Shares of Reitmans (Canada) Limited ("Reitmans"), bringing its total holdings in the company to 7,066,100 Class A Shares or approximately 13.8% of the total Class A Shares outstanding. The shares were purchased through the facilities of the Toronto Stock Exchange at a price of $6.35 per Class A Share for investment purposes. Fairfax continually reviews its investment alternatives and may purchase additional shares of Reitmans from time to time in accordance with applicable laws.

The Last Stand for BlackBerry Ltd. Against Apple and Google
Dan Caplinger, The Motley Fool - Motley Fool - Wed Dec 18, 10:04PM CST
Blackberry will release its quarterly report on Friday, and investors have largely lost hope in the Canadian smartphone pioneer ever recovering from its long slide. Despite once having dominated the mobile-device industry with its innovative...

BlackBerry Extends Purchase Option Deadline for Additional Convertible Debentures
Marketwire - Thu Dec 12, 5:01PM CST
BlackBerry Limited (NASDAQ: BBRY)(TSX: BB), a world leader in mobile communications, announced today that it has agreed with Fairfax Financial Holdings Limited and the holders of a requisite majority of the US$1 billion of convertible debentures issued by BlackBerry on November 13, 2013 that the previously-announced investor option to purchase up to an additional US$250 million principal amount of convertible debentures has been extended to January 13, 2014. If the option is exercised, the purchase of the additional convertible debentures will be completed on or before January 16, 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Two Xinjiang Histories Arrive With a Clear State Lens

Updated Category News Views 162

Dusty chronology rarely carries this much present-day weight. Two books released in Beijing on September 2, The History of China's Xinjiang Region and The Religious History in China's Xinjiang Region, are presented as the most comprehensive works on the subject yet produced by Chinese scholars. That is a sizable claim, and it deserves to be read with both attention and a...

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 80

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 0

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
TD Pledges $2 Billion to Financial Strength by 2036

Updated Category News Views 83

A Longer-Term Bet on Household Resilience A bank’s community budget rarely grabs the market by the collar, but TD’s new target deserves more than a polite nod. The bank says it will direct $2 billion, or US$1.4 billion, toward helping people build financial strength across North America over the next decade. That is a sizable commitment, even for an institution with...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 59

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 19

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
RMT’s 12.4% Discount Still Demands a Much Harder Look

Updated Category News Views 119

A $1.84 gap is staring RMT shareholders right in the face. As of October 31, 2026, Royce Micro-Cap Trust carried a net asset value of $14.82 per share while the market price sat at $12.98. That is roughly a 12.4% discount to NAV, and closed-end fund investors should never wave off a spread like that with a lazy shrug. It may be opportunity. It may also be the market...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 126

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Sleep Number’s Couples Pitch Has Some Fine Print Too

Updated Category News Views 40

A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 20

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading

Top 5 Most Recently Viewed Articles

Raphael Bostic's Forecast for Interest Rate Cuts in 2024

Updated Category News Views 139

Fed's Bostic Discusses Future Interest Rate Cuts Atlanta Federal Reserve President Raphael Bostic has recently shared his insights regarding future interest rate adjustments. At a recent event in Atlanta, Bostic indicated that he has projected a further interest rate decrease of 25 basis points this year. This update follows his review of the central bank's recent...

Continue Reading
Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 169

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Michael Saylor Advocates for U.S. Leadership in Cryptocurrency

Updated Category News Views 123

Michael Saylor's Vision for Digital Assets Michael Saylor, the co-founder of Strategy Inc. and a prominent advocate for Bitcoin, recently held discussions with key figures in the House Financial Services Committee. His conversations focused on strategies to position the United States as a leading authority in the world of Bitcoin and cryptocurrencies. The Digital Assets...

Continue Reading
Gents Doctor Unveils Insights on Testosterone Therapy and Health

Updated Category News Views 297

Gents Doctor Shares New Insights on Testosterone Therapy Gents Doctor, a well-known male health clinic led by Dr. Majid Sabour, MD, has recently unveiled two important blog posts that explore significant topics related to Testosterone Replacement Therapy (TRT). These posts are designed to inform men who are interested in improving their health through hormone...

Continue Reading
Promising Results from Phase III POLARIS-1 Study of Olverembatinib

Updated Category News Views 233

Exciting Developments in the Treatment of Ph+ ALL At the recent American Society of Hematology (ASH) meeting, cutting-edge research on Olverembatinib, a promising drug from Ascentage Pharma, highlighted its impressive efficacy for patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The findings from the Phase III...

Continue Reading